Down-regulating sphingolipid synthesis increases yeast lifespan.
Down-regulating sphingolipid synthesis increases yeast lifespan.
复制标题
DOI:
10.1371/journal.pgen.1002493
复制
发表时间:
2012-02
期刊:
影响因子:
4.5
通讯作者:
Dickson RC
中科院分区:
文献类型:
--
作者:
Huang X;Liu J;Dickson RC
Knowledge of the mechanisms for regulating lifespan is advancing rapidly, but lifespan is a complex phenotype and new features are likely to be identified. Here we reveal a novel approach for regulating lifespan. Using a genetic or a pharmacological strategy to lower the rate of sphingolipid synthesis, we show that Saccharomyces cerevisiae cells live longer. The longer lifespan is due in part to a reduction in Sch9 protein kinase activity and a consequent reduction in chromosomal mutations and rearrangements and increased stress resistance. Longer lifespan also arises in ways that are independent of Sch9 or caloric restriction, and we speculate on ways that sphingolipids might mediate these aspects of increased lifespan. Sch9 and its mammalian homolog S6 kinase work downstream of the target of rapamycin, TOR1, protein kinase, and play evolutionarily conserved roles in regulating lifespan. Our data establish Sch9 as a focal point for regulating lifespan by integrating nutrient signals from TOR1 with growth and stress signals from sphingolipids. Sphingolipids are found in all eukaryotes and our results suggest that pharmacological down-regulation of one or more sphingolipids may provide a means to reduce age-related diseases and increase lifespan in other eukaryotes. Studies with rats in the 1930s showed a surprising increase in lifespan when the diet contained 30%–40% fewer calories than normal. This experiment has been repeated on many organisms and is the gold standard for extending lifespan. While we are beginning to understand how calorie restriction regulates lifespan, the mechanisms are complex and much remains to be learned. In the work presented here, we demonstrate a novel way to increase lifespan in the budding yeast Saccharomyces cerevisiae. Our strategy is to lower the rate of sphingolipid synthesis either by reducing the synthesis of the first enzyme in the biosynthesis pathway or by using a drug to reduce enzyme activity. This strategy works in part by lowering the activity of a protein kinase, termed Sch9 in yeast and S6K in mammals, both of which are involved in the processes affected by calorie restriction and that control lifespan. In addition, we find that reducing sphingolipid synthesis increases lifespan in ways that are independent of Sch9 and calorie restriction. Since sphingolipids are found in all eukaryotes, our results suggest that pharmacological down-regulation of one or more sphingolipids may provide a means to reduce age-related diseases and increase lifespan in other eukaryotes.
登录
查看更多内容
DOI:
10.1126/science.1173635
发表时间:
2009-07-10
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Colman RJ;Anderson RM;Johnson SC;Kastman EK;Kosmatka KJ;Beasley TM;Allison DB;Cruzen C;Simmons HA;Kemnitz JW;Weindruch R
通讯作者:
Weindruch R
影响因子:
4.8
作者:
Dickson, RC;Nagiec, EE;Lester, RL
通讯作者:
Lester, RL
影响因子:
4.8
作者:
Chung, NJ;Mao, CG;Obeid, LM
通讯作者:
Obeid, LM
影响因子:
29
作者:
Bjedov I;Toivonen JM;Kerr F;Slack C;Jacobson J;Foley A;Partridge L
通讯作者:
Partridge L
DOI:
10.1016/j.tem.2009.11.005
发表时间:
2010-03
期刊:
Trends in endocrinology and metabolism: TEM
影响因子:
--
作者:
Anderson RM;Weindruch R
通讯作者:
Weindruch R